Mueller-Schoell, Anna http://orcid.org/0000-0002-5936-1877
Michelet, Robin http://orcid.org/0000-0002-5485-607X
Weinelt, Ferdinand
Kloft, Charlotte
Mikus, Gerd http://orcid.org/0000-0003-1783-133X
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 13 April 2021
Accepted: 17 May 2021
First Online: 24 May 2021
Declarations
:
: C.K. reports grants from an industry consortium (AbbVie Deutschland GmbH and Co. KG, AstraZeneca Ltd, Boehringer Ingelheim Pharma GmbH & Co. KG, Grünenthal GmbH, F. Hoffmann-La Roche Ltd, Merck KGaA and Sanofi) for the PharMetrX PhD program and from the Federal Ministry of Education and Research as well as the European Commission for the Innovative Medicines Initiative-Joint Undertaking, all outside the submitted work. The other authors declare that they have no conflict of interest.
: The manuscript does not contain clinical studies or patient data.
: Not applicable.
: Not applicable.
: Not applicable.